Literature DB >> 12498492

Changing utilization of stereotactic radiosurgery in the UK: the Sheffield experience.

J G Rowe1, M W R Radatz, L Walton, A A Kemeny.   

Abstract

Recognizing a change in our workload and variabilities in referral patterns, we reviewed our previous activity from 1994 to 2000 retrospectively and examined prospectively formal referrals to the Unit in 2001. Arteriovenous malformations still constitute 30% of referrals and treatments, although as a proportion of our workload, this has declined. Radiosurgery is increasingly being chosen as a first line treatment for small and moderate-sized acoustic neuromas, although referral rates vary widely, some neuroscience units referring all and others none of their acoustic neuromas at least for a radiosurgical opinion. About 100 meningiomas, mainly skull-base and/or recurrent tumours after previous surgery, are now treated per year. Compared with other units world-wide, very few pituitary adenomas and cerebral metastases are treated. The implications of this are discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12498492     DOI: 10.1080/0268869021000030294

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

1.  Gamma knife stereotactic radiosurgery for unilateral acoustic neuromas.

Authors:  J G Rowe; M W R Radatz; L Walton; A Hampshire; S Seaman; A A Kemeny
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

2.  Detection of rotational errors in single-isocenter multiple-target radiosurgery: Is a routine off-axis Winston-Lutz test necessary?

Authors:  Lauren M M Pudsey; Giordano Biasi; Anna Ralston; Anatoly Rosenfeld; Joel Poder
Journal:  J Appl Clin Med Phys       Date:  2022-06-17       Impact factor: 2.243

3.  Current status of intra-cranial stereotactic radiotherapy and stereotactic radiosurgery in Australia and New Zealand: key considerations from a workshop and surveys.

Authors:  Lauren Pudsey; Annette Haworth; Paul White; Zoe Moutrie; Benjamin Jonker; Matthew Foote; Joel Poder
Journal:  Phys Eng Sci Med       Date:  2022-02-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.